Effects of the phenacetin metabolite 4-nitrosophenetol on the glutathione status and the transport of glutathione S-conjugates in human red cells.
The extent of ferrihemoglobin formation in human erythrocytes by 4-nitrosophenetol and its metabolisation rate strongly depended on the availability of cellular GSH. Ferrihemoglobin formation rate was increased by inhibition of the red cell glutathione reductase, and 4-nitrosophenetol disappeared more slowly. When red cells were completely depleted from SH groups, ferrihemoglobin formation was retarded, despite 4-nitrosophenetol was hardly metabolized. In turn, the glutathione status of human red cells was strongly affected by 4-nitrosophenetol. GSSG, which was produced in large amounts, was reduced, as long as the reducing system was intact. The decreased total glutathione content, however, did not recover completely, indicating formation of stable glutathione S-conjugates. The active export of the stable model glutathione thioether S-(2,4-dinitrophenyl)glutathione was strongly inhibited by 4-nitrosophenetol. A Lineweaver-Burk plot of the transport data suggested a competitive inhibition mechanism, presumably caused by glutathione adducts. The results indicate that the strong pi-donor substituent in 4-nitrosophenetol enables metabolic reactions with glutathione, producing biological effects hitherto not observed with nitrosobenzene. Bicyclic arylamines and glutathione S-conjugates may cause ferrihemoglobin formation that is not brought about by the diaphorase reaction. The latter may be responsible for transport inhibition of GSSG and other glutathione S-conjugates.
Gallemann
D
D
Walther-Straub-Institut für Pharmakologie und Toxikologie, Ludwig-Maximilians-Universität München.
Eyer
P
P
D001692:Biological Transport / Q000187:drug effects; D004137:Dinitrochlorobenzene / Q000494:pharmacology; D004912:Erythrocytes / Q000187:drug effects* / Q000378:metabolism; D005978:Glutathione / Q000031:analogs & derivatives* / Q000097:blood* / Q000737:chemistry; D019803:Glutathione Disulfide; D006801:Humans; D066298:In Vitro Techniques; D008706:Methemoglobin / Q000096:biosynthesis; D010084:Oxidation-Reduction; D010615:Phenacetin / Q000031:analogs & derivatives* / Q000494:pharmacology
D004137:Dinitrochlorobenzene; C030190:S-(2,4-dinitrophenyl)glutathione; C037221:4-nitrosophenetole; D008706:Methemoglobin; D010615:Phenacetin; D005978:Glutathione; D019803:Glutathione Disulfide